Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Completed 2Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 4Thoracic 2Other 2Gastrointestinal 2Tumor-Agnostic 1Lymphoid 1Head & Neck 1Gynecologic 1Endocrine 1

Conditions

Breast Neoplasms 4Pain, Postoperative 3Inflammation 1Agnosia 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 485Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 151Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Anti-Inflammatory Agents, Non-Steroidal × Breast × Clear all
NCT05876390 2026-04-16

IRACPoP

Niguarda Hospital

Enrolling by invitation
1,500 enrolled
Breast

Breast Neoplasms, Pain, Postoperative

NCT05829707 2023-04-28

Long-term Outcomes of Breast Cancer Patients After Wound Infiltration Analgesia

Osijek University Hospital

Phase 4 Completed
120 enrolled
Breast

Breast Neoplasms, Pain, Postoperative

NCT02141139 2014-05-19

Perioperative Inflammation and Breast Cancer Outcome

Samsung Medical Center

Phase 3 Unknown
1,568 enrolled
Breast

Breast Neoplasms, Inflammation

NCT00519246 2009-03-31

COPTEAM

Nanjing Medical University

Phase 4 Completed
2,000 enrolled
Breast

Agnosia, Breast Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡